Financier | Commitments |
---|---|
International Bank for Reconstruction and Development | 90.00 |
P175895
Active
Shuo Zhang
Ministry of Finance of Ukraine
March 12, 2021
(as of board presentation)
May 10, 2021
July 30, 2021
US$ 240.00 million
Ministry of Health of Ukraine
2021
US$ 90.00 million
N/A
October 9, 2023
March 31, 2025
Yes
BANK APPROVED
Financier | Commitments |
---|---|
International Bank for Reconstruction and Development | 90.00 |
Product Line | IBRD/IDA |
---|---|
IBRD Commitment | 90.00 |
IDA Commitment | N/A |
IBRD + IDA Commitment | 90.00 |
Lending Instrument | |
---|---|
Grant Amount | N/A |
Total Project Cost** | 240.00 |
Period | Financier | Transaction Type | Amount (US$) |
---|---|---|---|
Dec 15, 2022 | IBRD-93150 | Int Charges | 2,268,725.00 |
Dec 15, 2022 | IBRD-93690 | Int Charges | 1,718,450.80 |
Apr 26, 2023 | IBRD-92500 | Loan Disb | 21,500.00 |
Apr 25, 2023 | IBRD-93150 | Loan Disb | 1,004,323.30 |
Jul 17, 2023 | IBRD-92500 | Loan Disb | 138,000.00 |
Jun 15, 2023 | IBRD-93150 | Int Charges | 154,392.00 |
Jun 15, 2023 | IBRD-93150 | Int Charges | 3,317,939.50 |
Jul 18, 2023 | IBRD-93150 | Loan Disb | 1,767,000.00 |
May 10, 2021 | IBRD-92500 | Loan Commitment | 90,000,000.00 |
Mar 7, 2022 | IBRD-93690 | Loan Commitment | 91,391,744.00 |
Dec 10, 2021 | IBRD-93150 | Loan Commitment | 150,000,000.00 |
Jul 3, 2024 | IBRD-92500 | Loan Disb | 752,189.10 |
Aug 24, 2023 | IBRD-92500 | Loan Disb | 219,683.10 |
Oct 31, 2023 | IBRD-92500 | Loan Disb | 512,593.90 |
Oct 15, 2023 | IBRD-92500 | Int Charges | 1,464.04 |
Oct 15, 2023 | IBRD-92500 | Int Charges | 62,509.87 |
Oct 15, 2023 | IBRD-92500 | Int Charges | 28,488.82 |
Oct 15, 2023 | IBRD-92500 | Int Charges | 2,052,210.50 |
Oct 18, 2023 | IBRD-92500 | Loan Disb | 401,275.28 |
Dec 19, 2023 | IBRD-92500 | Loan Disb | 425,000.00 |
Dec 15, 2023 | IBRD-93150 | Int Charges | 38.84 |
Nov 28, 2023 | IBRD-92500 | Loan Disb | 2,259,000.00 |
Dec 15, 2023 | IBRD-93150 | Int Charges | 73,743.59 |
Dec 15, 2023 | IBRD-93150 | Int Charges | 32,446.09 |
Dec 15, 2023 | IBRD-93150 | Int Charges | 3,893,232.50 |
Dec 6, 2023 | IBRD-93150 | Loan Disb | 1,106,000.00 |
Dec 15, 2023 | IBRD-93690 | Int Charges | 48,602.21 |
Dec 15, 2023 | IBRD-93690 | Int Charges | 2,868,305.20 |
Dec 4, 2023 | IBRD-92500 | Loan Disb | 88,524.60 |
Dec 27, 2023 | IBRD-92500 | Loan Disb | 57,837.40 |
Nov 30, 2023 | IBRD-93150 | Loan Disb | 239,973.66 |
Dec 27, 2023 | IBRD-92500 | Loan Disb | 138,480.48 |
Dec 21, 2023 | IBRD-93150 | Loan Disb | 185,000.00 |
Dec 21, 2023 | IBRD-93150 | Loan Disb | 322,000.00 |
Oct 10, 2023 | IBRD-93150 | Loan Disb | 99,000.00 |
Dec 22, 2023 | IBRD-93150 | Loan Disb | 1,337,000.00 |
Sep 11, 2023 | IBRD-92500 | Loan Disb | 1,214,858.40 |
Jul 31, 2023 | IBRD-92500 | Loan Disb | 76,139.40 |
Mar 17, 2023 | IBRD-93150 | Loan Disb | 111,591.49 |
Oct 19, 2021 | IBRD-92500 | Loan Disb | 30,000,000.00 |
Jul 30, 2021 | IBRD-92500 | Loan Disb | 225,000.00 |
Jul 30, 2021 | IBRD-92500 | Fee Charges | 225,000.00 |
Jun 30, 2022 | IBRD-93150 | Loan Disb | 300,000.00 |
Mar 8, 2022 | IBRD-93690 | Fee Charges | 228,479.34 |
Mar 8, 2022 | IBRD-93690 | Loan Disb | 228,479.34 |
Jul 5, 2024 | IBRD-93150 | Loan Disb | 1,188,000.00 |
Sep 3, 2024 | IBRD-93150 | Loan Disb | 763,071.40 |
May 8, 2024 | IBRD-92500 | Loan Disb | 102,756.49 |
Jul 5, 2024 | IBRD-92500 | Loan Disb | 912,179.40 |
Aug 9, 2024 | IBRD-93150 | Loan Disb | 919,040.25 |
Apr 15, 2024 | IBRD-92500 | Int Charges | 382.17 |
Apr 29, 2024 | IBRD-92500 | Loan Disb | 770,000.00 |
Apr 29, 2024 | IBRD-93150 | Loan Disb | 1,589,000.00 |
Apr 15, 2024 | IBRD-92500 | Int Charges | 32,556.72 |
Apr 15, 2024 | IBRD-92500 | Int Charges | 20,875.33 |
Apr 15, 2024 | IBRD-92500 | Int Charges | 2,438,180.80 |
Feb 20, 2024 | IBRD-93150 | Loan Disb | 82,500.00 |
Jun 1, 2022 | IBRD-92500 | Loan Disb | 517,563.00 |
Nov 29, 2021 | IBRD-92500 | Loan Disb | 5,944,536.00 |
Jun 15, 2022 | IBRD-93690 | Int Charges | 276,997.78 |
Jun 15, 2022 | IBRD-93150 | Int Charges | 607,785.25 |
Dec 13, 2021 | IBRD-93150 | Loan Disb | 375,000.00 |
Dec 13, 2021 | IBRD-93150 | Fee Charges | 375,000.00 |
Mar 14, 2022 | IBRD-93690 | Loan Disb | 91,163,264.00 |
Apr 15, 2022 | IBRD-92500 | Int Charges | 466.83 |
Apr 15, 2022 | IBRD-92500 | Int Charges | 208,533.66 |
Dec 28, 2022 | IBRD-92500 | Loan Disb | 120,643.68 |
Dec 21, 2022 | IBRD-93150 | Loan Disb | 160,000.00 |
Dec 20, 2021 | IBRD-93150 | Loan Disb | 105,007,760.00 |
Dec 21, 2021 | IBRD-92500 | Loan Disb | 1,619,082.00 |
Feb 28, 2022 | IBRD-93150 | Loan Disb | 14,992,238.00 |
Mar 1, 2022 | IBRD-92500 | Loan Disb | 4,891,989.00 |
Dec 27, 2021 | IBRD-92500 | Loan Disb | 14,723,388.00 |
Nov 7, 2022 | IBRD-92500 | Loan Disb | 7,700.00 |
Nov 8, 2022 | IBRD-92500 | Loan Disb | 31,500.00 |
Oct 15, 2022 | IBRD-92500 | Int Charges | 5,748.08 |
Oct 15, 2022 | IBRD-92500 | Int Charges | 810,354.10 |
Apr 15, 2023 | IBRD-92500 | Int Charges | 59,296.87 |
Apr 15, 2023 | IBRD-92500 | Int Charges | 32,618.09 |
Apr 15, 2023 | IBRD-92500 | Int Charges | 1,449,625.00 |
Feb 3, 2023 | IBRD-92500 | Loan Disb | -918.45 |
Feb 3, 2023 | IBRD-92500 | Loan Disb | 46,000.00 |
Mar 20, 2023 | IBRD-92500 | Loan Disb | 8,176,702.00 |
Mar 20, 2023 | IBRD-92500 | Loan Disb | 44,500.00 |
Apr 28, 2023 | IBRD-93150 | Loan Disb | 129,878.93 |
Dec 15, 2022 | IBRD-93690 | Int Charges | 52,502.93 |
Sep 15, 2022 | IBRD-92500 | Loan Disb | 17,000.00 |
Dec 20, 2022 | IBRD-92500 | Loan Disb | 28,000.00 |
Aug 2, 2024 | IBRD-93150 | Loan Disb | 1,043,607.44 |
Feb 9, 2024 | IBRD-92500 | Loan Disb | 3,012,165.20 |
Feb 13, 2024 | IBRD-93150 | Loan Disb | 3,750,742.20 |
Aug 26, 2024 | IBRD-92500 | Loan Disb | 2,743,394.00 |
May 3, 2024 | IBRD-92500 | Loan Disb | 905,000.00 |
Apr 8, 2024 | IBRD-92500 | Loan Disb | 715,129.80 |
Jun 15, 2024 | IBRD-93150 | Int Charges | 26,889.10 |
Jun 15, 2024 | IBRD-93150 | Int Charges | 24,154.48 |
Jun 15, 2024 | IBRD-93150 | Int Charges | 4,333,360.50 |
Jun 28, 2024 | IBRD-93150 | Loan Disb | 2,000,000.00 |
Jun 15, 2024 | IBRD-93690 | Int Charges | 18,171.75 |
Jun 15, 2024 | IBRD-93690 | Int Charges | 3,040,202.00 |
Jun 15, 2024 | IBRD-93150 | Int Charges | 92.82 |
Jun 6, 2024 | IBRD-92500 | Loan Disb | 134,519.45 |
Mar 17, 2023 | IBRD-93150 | Loan Disb | 350,670.03 |
Jul 28, 2023 | IBRD-92500 | Loan Disb | 959,000.00 |
Jul 28, 2023 | IBRD-92500 | Loan Disb | 92,544.75 |
Jun 15, 2023 | IBRD-93690 | Int Charges | 116,927.72 |
Jun 15, 2023 | IBRD-93690 | Int Charges | 2,504,706.20 |
Sep 25, 2023 | IBRD-93150 | Loan Disb | 281,200.00 |
Jun 15, 2023 | IBRD-93150 | Int Charges | 944.13 |
Aug 24, 2023 | IBRD-92500 | Loan Disb | 59,016.40 |
Name | Review | Date |
---|---|---|
Overall Implementation Progress (IP) | Satisfactory | 2025-01-23 |
Project Management | Satisfactory | 2025-01-23 |
Monitoring and Evaluation | Satisfactory | 2025-01-23 |
Progress towards achievement of PDO | Satisfactory | 2025-01-23 |
Procurement | Satisfactory | 2025-01-23 |
Financial Management | Moderately Satisfactory | 2025-01-23 |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Number of health care facilities participating in the COVID-19 vaccination program that have functional cold chain and/or waste management equipment | Value | 0.00 | 1159.00 | 1000.00 |
Date | January 1, 2021 | August 31, 2023 | September 30, 2024 | |
Comment |
Number of individuals from a baseline of 0 from priority population groups that have received full COVID-19 vaccination from selected health care providers following the agreed procedures | Value | 0.00 | 5105426.00 | 5200000.00 |
Date | January 1, 2021 | August 31, 2023 | September 30, 2024 | |
Comment |
Daily maximum number of Government-financed tests for COVID-19 | Value | 41885.00 | 78027.00 | 60000.00 |
Date | April 30, 2021 | August 31, 2023 | September 30, 2024 | |
Comment |
of them males | Value | 0.00 | 1960089.00 | 2080000.00 |
Date | January 1, 2021 | August 31, 2023 | September 30, 2024 | |
Comment |
Number of health care facilities that have access to project-supported power generation equipment (Number) | Value | 0.00 | 0.00 | 300.00 |
Date | October 31, 2022 | August 31, 2023 | September 30, 2024 | |
Comment |
of them females | Value | 0.00 | 3145337.00 | 3120000.00 |
Date | January 1, 2021 | August 31, 2023 | September 30, 2024 | |
Comment |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
The National COVID-19 Vaccination Deployment Roadmap, prepared and approved by the Government of Ukraine, is regularly updated | Value | Yes | Yes | Yes |
Date | January 1, 2021 | August 31, 2023 | September 30, 2024 | |
Comment |
Guidelines, documented procedures and tools for planning and conducting vaccine pharmacovigilance activities | Value | No | Yes | Yes |
Date | January 1, 2021 | August 31, 2023 | September 30, 2024 | |
Comment |
Vaccine stock management tools and operating procedures updated to reflect the characteristics of COVID-19 vaccines | Value | No | Yes | Yes |
Date | January 1, 2021 | August 31, 2023 | September 30, 2024 | |
Comment |
Number of health workers trained in infection prevention and control | Value | 0.00 | 0.00 | 1000.00 |
Date | January 1, 2021 | August 31, 2023 | September 30, 2024 | |
Comment |
Standard operating procedures (SOPs) or guidelines established for collection and disposal of medical waste to the relevant stakeholders | Value | No | Yes | Yes |
Date | January 1, 2021 | August 31, 2023 | September 30, 2024 | |
Comment |
of them males | Value | 0.00 | 0.00 | 300.00 |
Date | January 1, 2021 | August 31, 2023 | September 30, 2024 | |
Comment |
National tools developed: vaccination card/certificate - facility-based nominal registers and/or tally sheets, vaccination reports (paper and/or electronic) to monitor vaccination | Value | No | Yes | Yes |
Date | January 1, 2021 | August 31, 2023 | September 30, 2024 | |
Comment |
of them females | Value | 0.00 | 0.00 | 700.00 |
Date | January 1, 2021 | August 31, 2023 | September 30, 2024 | |
Comment |
Health information system collecting sex and age disaggregated data on COVID-19 indicators for testing and vaccines | Value | No | Yes | Yes |
Date | January 1, 2021 | August 31, 2023 | September 30, 2024 | |
Comment |
Number of calls to the COVID-19 hotline are received and addressed to advise on COVID-19 vaccination | Value | 0.00 | 287869.00 | 350000.00 |
Date | January 1, 2021 | August 31, 2023 | September 30, 2024 | |
Comment |
Number of doses of COVID-19 vaccine procured with Project funding | Value | 0.00 | 28321150.00 | 28320000.00 |
Date | April 1, 2021 | August 31, 2023 | December 30, 2022 | |
Comment |
calls received and addressed from females | Value | 0.00 | 140193.00 | 245000.00 |
Date | January 1, 2021 | August 31, 2023 | September 30, 2024 | |
Comment |
Electronic appointment for vaccination is used to deploy vaccinations for eligible patients. | Value | 0.00 | 0.00 | 30.00 |
Date | November 15, 2021 | March 31, 2023 | September 30, 2024 | |
Comment |
calls received and addressed from males | Value | 0.00 | 98213.00 | 105000.00 |
Date | January 1, 2021 | August 31, 2023 | September 30, 2024 | |
Comment |
Share of project-supported primary care facilities that used the citizen feedback to enhance the access and quality of COVID-19 vaccinations | Value | 0.00 | 66.70 | 40.00 |
Date | January 1, 2021 | August 31, 2023 | September 30, 2024 | |
Comment |
Communication and community mobilization campaign for COVID-19 vaccination that is targeting priority populations is implemented and monitored | Value | No | Yes | Yes |
Date | November 15, 2021 | August 31, 2023 | September 30, 2024 | |
Comment |